Antiviral activity of 5-aminolevulinic acid against variants of severe acute respiratory syndrome coronavirus 2
Available in National Diet Library
Find on the publisher's website
NDL Digital Collections
Digital data available
Check on the publisher's website
DOI[10.1186/s41182-021-00397-x]to the data of the same series
Holdings of Libraries in Japan
This page shows libraries in Japan other than the National Diet Library that hold the material.
Please contact your local library for information on how to use materials or whether it is possible to request materials from the holding libraries.
other
CiNii Research
Search ServiceDigitalYou can check the holdings of institutions and databases with which CiNii Research is linked at the site of CiNii Research.
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 記事
- Author/Editor
- Mya Myat Ngwe TunTakaya SakuraYasuteru Sakurai
- Publication, Distribution, etc.
- Publication Date
- 2022-01-07
- Publication Date (W3CDTF)
- 2022-01-07
- Periodical title
- Tropical medicine and health
- No. or year of volume/issue
- 50(6)
- Volume
- 50(6)
- ISSN (Periodical Title)
- 1349-4147
- ISSN-L (Periodical Title)
- 1348-8945
- Text Language Code
- eng
- DOI
- 10.1186/s41182-021-00397-x
- Persistent ID (NDL)
- info:ndljp/pid/12307900
- Collection
- Collection (Materials For Handicapped People:1)
- Collection (particular)
- 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- Acquisition Basis
- オンライン資料収集制度
- Date Accepted (W3CDTF)
- 2022-07-11T22:10:26+09:00
- Date Captured (W3CDTF)
- 2022-07-11
- Format (IMT)
- application/pdf
- Access Restrictions
- 国立国会図書館内限定公開
- Service for the Digitized Contents Transmission Service
- 図書館・個人送信対象外
- Availability of remote photoduplication service
- 可
- Periodical Title (URI)
- Periodical Title (Persistent ID (NDL))
- info:ndljp/pid/12307894
- Data Provider (Database)
- 国立国会図書館 : 国立国会図書館デジタルコレクション
- Summary, etc.
- コレクション : 国立国会図書館デジタルコレクション > 電子書籍・電子雑誌 > その他
- DOI
- 10.1186/s41182-021-00397-x
- Related Material (URI)
- Is Referenced By
- Construction of 5-aminolevulinic acid synthase variants by cysteine-targeted mutation to release heme inhibition5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
- References
- Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndromeSugiyama, Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer TherapyN. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome5‐Aminolevulinic acid can ameliorate language dysfunction of patients with ATR‐X syndromeSARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionPreclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID195-amino levulinic acid inhibits SARS-CoV-2 infection in vitro5-Aminolevulinic acid regulates the inflammatory response and alloimmune reactionOral administration of 5-aminolevulinic acid induces heme oxygenase-1 expression in peripheral blood mononuclear cells of healthy human subjects in combination with ferrous iron<i>In Vivo</i> Curative and Protective Potential of Orally Administered 5-Aminolevulinic Acid plus Ferrous Ion against MalariaPerspectives for Applying G-Quadruplex Structures in Neurobiology and NeuropharmacologyDiscovery of G-quadruplex-forming sequences in SARS-CoV-2G-quadruplex structures: in vivo evidence and functionmRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variantsSevere Acute Respiratory Syndrome Coronavirus 2 P.2 Lineage Associated with Reinfection Case, Brazil, June–October 2020Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanismsG-Quadruplexes Are Present in Human Coronaviruses Including SARS-CoV-2Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 TherapeuticsA Genomic Perspective on the Origin and Emergence of SARS-CoV-2Neurological Manifestations of COVID-19 (SARS-CoV-2): A ReviewNeutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited seraCase Reports: Safety, Tolerability, and Efficacy of 5-Aminolevulinic Acid Phosphate, an Inducer of Heme Oxygenase 1, in Combination with Sodium Ferrous Citrate for the Treatment of COVID-19 PatientsMolnupiravir, an Oral Antiviral Treatment for COVID-19Pharmacological prospects of G-quadruplexes for neurological diseases using porphyrinsCo-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelopeSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorG-quadruplex forming sequences in the genome of all known human viruses: A comprehensive guideDrug repositioning: identifying and developing new uses for existing drugsEscape from neutralizing antibodies by SARS-CoV-2 spike protein variantsClinical Pharmacokinetics of 5-Aminolevulinic Acid in Healthy Volunteers and Patients at High Risk for Recurrent Bladder CancerGenomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor bindingClinical characteristics of asymptomatic and symptomatic patients with mild COVID-19heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-α/βGastrointestinal symptoms of 95 cases with SARS-CoV-2 infectionAminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for EnhancementThe G-Quadruplex/Helicase World as a Potential Antiviral Approach Against COVID-19Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IXCoronavirus disease 2019: What we know?Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptorEarly Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected PneumoniaRemdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialA global database of COVID-19 vaccinationsSafety and Mode of Action of Diabetes Medications in comparison with 5-Aminolevulinic Acid (5-ALA)Targeting RNA G‐Quadruplex in SARS‐CoV‐2: A Promising Therapeutic Target for COVID‐19?Diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in JapanHealth-related Quality of Life and Undergraduate Nursing Students: A Narrative Review.
- Data Provider (Database)
- 国立情報学研究所 : CiNii Research
- Original Data Provider (Database)
- 雑誌記事索引データベースCrossref科学研究費助成事業データベース科学研究費助成事業データベース科学研究費助成事業データベースCrossrefCrossref
- Bibliographic ID (NDL)
- 12307900